UVA scientists develop AI tool to accelerate the development of new disease treatments
University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments.
Read moreUniversity of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments.
Read moreA large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led
Read moreNew research reveals that older adults who maintain strong cardiovascular health show fewer signs of brain degeneration—offering hope for preventing
Read moreAlthough the Food and Drug Administration (FDA) located H5N1 bird flu virus in samples of raw, or unpasteurized, milk in
Read moreA research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A
Read moreResearchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW) is distinct
Read moreHidden risks in plain sight: New research reveals how children with autism can suffer life-altering vitamin deficiencies despite appearing healthy,
Read moreBIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex
Read moreWater/aqua aerobics for 10 or more weeks at a time can trim waist size and aid weight loss, finds a
Read moreThe disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound
Read more